Tsuyoshi Inoshita in Portsmouth, Ohio

Home Ohio Portsmouth

Tsuyoshi Inoshita has Hematology/oncology as his primary medical specialty. Their primary office is: 916 11th St in Portsmouth, Ohio. There is an additional office location, for a total of two, for Tsuyoshi Inoshita that can be viewed further down.

They're a part of the: Kings Daughters Medical Specialties Inc medical group which has around 323 members. You can call their office at 740-353-4884 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1975 (around 49 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Tsuyoshi Inoshita Office Phone and Directions

Tsuyoshi Inoshita
Kings Daughters Medical Specialties Inc
916 11th St
Portsmouth, Ohio 45662
740-353-4884

Patient Ratings
Please rate your experience with Tsuyoshi Inoshita below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 740-353-4884

Enter a starting address:

Healthcare Info for Tsuyoshi Inoshita

Medical School: Sorry, his university is not listed
Graduation Year: 1975
The Primary Medical Specialty for Tsuyoshi Inoshita is listed as: Hematology/oncology
Approximate Years of Experience: 49
PAC (PECOS ID)#: 6901859396
NPI #: 1598756363
NPI Created On: 11/02/2005
NPI Last Updated Listed as: 05/19/2015
Primary Taxonomy Code: 207RH0003X
License Number:
45856
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

MOLINA HEALTHCARE OF OHIO
Humana
CareSource
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Japanese.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
New patient office or other outpatient visit, typically 30 minutes
New patient office or other outpatient visit, typically 45 minutes
Established patient office or other outpatient visit, typically 10 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Initial hospital inpatient care, typically 30 minutes per day
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 15 minutes per day
Hospital discharge day management, 30 minutes or less

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $1,170

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third Party:: Tsuyoshi Inoshita, M.D., INC

Third party is a Charity:: No

Record ID:: 788452401

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $9

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788452387

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $9

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788452396

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788452391

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781011279

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781011281

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781011283

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818801859

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818801861

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818818087

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Additional Office Locations

1. Kings Daughters Medical Specialties Inc
1242 Crescent Dr
Wheelersburg, OH 45694
Group Members: 323

Phone: 740-353-4884

Enter a starting address:

Hematology/oncology Professionals in Portsmouth

1.
Hassaan Jafri

1901 Argonne Rd
Portsmouth, OH
Kings Daughters Medical Specialties Inc

2.
Hassaan Jafri

916 11th St
Portsmouth, OH
Kings Daughters Medical Specialties Inc

3.
David Goebel

916 11th St
Portsmouth, OH
Kings Daughters Medical Specialties Inc

4.
Nanda Methuku

1805 27th St
Portsmouth, OH
Somc Medical Care Foundation, Inc.

5.
Nanda Methuku

1121 Kinneys Ln
Portsmouth, OH
Somc Medical Care Foundation, Inc.

Providers in Kings Daughters Medical Specialties Inc

1.Hassan Abul Khoudoud

1200 Central Ave
Ashland Ky 41101-7575
Kings Daughters Medical Specialties Inc
Family Practice

2.Omran Abul-khoudoud Md

2201 Lexington Ave
Ashland Ky 41101-2843
Kings Daughters Medical Specialties Inc
Vascular Surgery

3.Omran Abul-khoudoud Md

613 23rd St
Ashland Ky 41101-2876
Kings Daughters Medical Specialties Inc
Vascular Surgery

4.Omran Abul-khoudoud Md

1901 Argonne Rd
Portsmouth Oh 45662-2827
Kings Daughters Medical Specialties Inc
Vascular Surgery

5.Omran Abul-khoudoud Md

1242 Crescent Dr
Wheelersburg Oh 45694-9376
Kings Daughters Medical Specialties Inc
Vascular Surgery

6.Omran Abul-khoudoud Md

1729 Kinneys Ln
Portsmouth Oh 45662-3167
Kings Daughters Medical Specialties Inc
Vascular Surgery

View all 323 members of Kings Daughters Medical Specialties Inc medical group